Eight lion cubs have died this week in Gujarat's Gir Somnath and Amreli districts due to suspected Babesia infection, a parasitic disease transmitted by ticks. Gujarat Forest Minister Arjun Modhwadia confirmed the deaths and stated that disease-control measures have been intensified around the Gir wildlife sanctuary. Large-scale tick-removal operations have been launched, and lions within a 10-km radius of affected areas are being isolated. Officials are treating the infection as a "potential threat" due to its rapid transmission possibility. Samples from the dead cubs have been sent for examination to confirm the cause of death.
- Eight lion cubs died in Gir Somnath and Amreli districts of Gujarat from suspected Babesia infection.
- Babesia is a parasitic disease transmitted through ticks, causing weakness, fever, coughing, and nasal discharge.
- The Forest Department has intensified disease-control measures, including large-scale tick-removal operations.
The National Health Accounts (NHA) Estimates for India 2022-23 indicate that households still bear nearly half of the current health expenditure (OOPE), despite increased government and insurance spending. While the government claims a rise in its health expenditure as a percentage of GDP, experts like Abhay Shukla point out that public financing has dropped back to pre-COVID levels, with GHE as a share of CHE sharply declining. Private health insurance expenditures are three times higher than government-financed schemes, suggesting PMJAY and similar programs fail to provide substantial protection. The health system remains deeply privatized, leading to inequities and high costs, with a low focus on preventive care.
- Out-of-pocket expenditure (OOPE) constitutes nearly half of India's current health expenditure, placing a significant burden on households.
- Despite government claims of increased public health spending, the share of Government Health Expenditure (GHE) in Current Health Expenditure (CHE) has declined sharply post-COVID.
- Private health insurance spending significantly outweighs government-financed schemes, indicating inadequate financial protection for citizens.
The Bundibugyo ebolavirus outbreak in Congo and Uganda has exposed a critical gap in international vaccine preparedness, as there is no licensed vaccine for this rare species. The article explains the complex and costly process of vaccine development, requiring BSL-4 facilities, primate trials, and substantial funding. It highlights that neglected tropical diseases (NTDs) like Bundibugyo ebolavirus suffer from "neglect" due to small commercial markets, lack of financial incentives for pharmaceutical companies, and the diseases primarily affecting poor, rural, and politically marginalized populations. Despite international declarations and initiatives, R&D remains patchy, compounded by weak healthcare systems.
- The Bundibugyo ebolavirus outbreak reveals a lack of licensed vaccines for this specific species.
- Vaccine development for such rare and neglected diseases is hindered by high costs, limited commercial incentives, and weak R&D infrastructure.
- Neglected Tropical Diseases (NTDs) disproportionately affect poor and marginalized populations, leading to insufficient investment.
India's out-of-pocket expenditure (OOPE) as a share of total health expenditure has significantly declined to 43.4% in 2022-23, from 64.2% in 2013-14. This decline is attributed to increased government health expenditure, particularly through the operationalization of Ayushman Arogya Mandir wellness centres, which provide free preventive and curative services. The report, based on National Health Accounts (NHA) estimates, also indicates an increase in government health expenditure as a percentage of GDP (from 1.15% to 1.43%) and general government expenditure (from 3.78% to 4.89%). The share of private health insurance has also risen, indicating improved health-seeking behavior.
- Out-of-pocket expenditure (OOPE) on health in India has decreased significantly.
- This reduction is linked to increased government health spending and the expansion of Ayushman Arogya Mandir wellness centres.
- Government health expenditure as a percentage of GDP and general government expenditure has risen.
Non-Communicable Diseases (NCDs) were responsible for 60% of all deaths in India during 2022-2024, a significant increase from 52.8% in 2015-2017, according to the SRS Statistical Report 2024. NCDs are more prevalent in urban areas (64.8%) and among men (62.3%). Cardiovascular diseases are the leading cause, accounting for 32.1% of all deaths and 37.3% in the 30-69 age group. India is undergoing an epidemiological transition, with chronic illnesses dominating mortality trends while infectious diseases remain a challenge. Suicide is the leading cause of death for the 15-29 age group (19%), indicating growing mental health pressures. Regional disparities show Empowered Action Group (EAG) states with lower NCD mortality (53.9%).
- NCDs are now the leading cause of death in India, accounting for 60% of all deaths in 2022-2024.
- Cardiovascular diseases are the primary NCD cause, significantly impacting the 30-69 age group.
- India is experiencing an epidemiological transition, with chronic diseases rising while infectious diseases persist.
India's Union Health Minister J. P. Nadda reviewed the country's preparedness and surveillance measures against the Ebola virus outbreak in Africa, expressing concern about its potential global spread. The Health Ministry confirmed that India has not reported any cases of Bundibugyo Ebola disease and is actively monitoring the situation, collaborating with the National Centre for Disease Control and other agencies. The Directorate General of Civil Aviation (DGCA) has issued directives for airlines, mandating passengers from affected regions to fill out health forms, and implementing segregated seating and personal protective equipment for suspected cases, alongside mask distribution for nearby passengers.
- India's Health Ministry is closely monitoring the Ebola virus situation in Africa and has strengthened national surveillance and preparedness.
- No cases of Bundibugyo Ebola disease have been reported in India to date.
- The DGCA has issued specific directives for airlines regarding passengers traveling from or transiting through Uganda or the Democratic Republic of Congo.
India is undergoing a significant demographic transition, moving from a 'population explosion' to an ageing population, as evidenced by the latest SRS bulletin (2024). The Total Fertility Rate (TFR) has dropped to 1.9, below the replacement level of 2.1, and the birth rate has fallen from 21 in 2014 to 18.3 in 2024. While India currently enjoys a demographic dividend with a median age of 29.2 years, this will eventually disappear. The article highlights the need for policy reassessment to address the needs of a greying nation, including better healthcare access, education, and addressing regional disparities in child survival and infant mortality rates.
- India's Total Fertility Rate (TFR) has fallen to 1.9, below the replacement level of 2.1, indicating a significant demographic shift.
- The country is transitioning from a young, expanding population to an ageing one, which will eventually lead to the disappearance of the demographic dividend.
- Factors like urbanisation, better education, and access to contraception contribute to the decline in fertility rates.
Ensitrelvir, an oral anti-COVID-19 drug, has been granted full authorization in Japan and shown to effectively prevent symptomatic COVID-19 infection post-exposure, reducing incidence by 67%. Developed by Shionogi, it targets the SARS-CoV-2 main protease (Mpro) using computational chemistry, avoiding the issues of Pfizer's Nirmatrelvir (Paxlovid). This drug represents a significant milestone beyond COVID-19, as it targets a protein common to betacoronaviruses, a sub-family responsible for SARS-CoV-1, MERS-CoV, and SARS-CoV-2. Its success provides scientists with a valuable starting point for rapidly developing drugs against future viral outbreaks.
- Ensitrelvir, an oral anti-COVID-19 drug, has received full authorization in Japan.
- Clinical trials (SCORPIO-PEP) showed Ensitrelvir reduced symptomatic COVID-19 incidence by 67% post-exposure.
- The drug targets the SARS-CoV-2 main protease (Mpro), a key enzyme for viral replication.
The Ebola outbreak in the Democratic Republic of Congo (DRC) has resulted in 204 deaths from 867 suspected cases across three provinces, with one death also reported in Uganda. The World Health Organization has declared the outbreak an international emergency. The Africa Centres for Disease Control and Prevention warned that ten other African countries are at risk, including Angola, Burundi, Central African Republic, Republic of Congo, Ethiopia, Kenya, Rwanda, South Sudan, Tanzania, and Zambia, highlighting the need for regional preparedness and response.
- The Ebola outbreak in the Democratic Republic of Congo (DRC) has caused over 200 deaths.
- The World Health Organization declared the outbreak an international emergency.
- One death was also reported in Uganda, indicating cross-border spread.
Infertility affects 10-15% of adults in India, yet it remains a neglected public health issue with minimal government policies or services. The sector is heavily privatized, making advanced treatments like IVF prohibitively expensive for many, with costs ranging from ₹1 lakh to ₹2.5 lakh per cycle, often requiring multiple cycles. Limited insurance coverage forces individuals to fund treatments out-of-pocket, leading to significant financial and emotional strain. Experts argue that reproductive autonomy, enshrined under Article 21, should encompass infertility care, not just contraception and abortion, highlighting a critical disconnect between constitutional promises and healthcare realities.
- Infertility impacts 10-15% of Indian adults but is largely ignored as a public health issue.
- The fertility treatment sector is dominated by private players, with high costs and negligible public health services.
- IVF treatments are expensive, ranging from ₹1 lakh to ₹2.5 lakh per cycle, often requiring multiple attempts.
Following the WHO's declaration of the Ebola outbreak in the Democratic Republic of Congo and Uganda as a Public Health Emergency of International Concern, the Indian Centre has instructed all States and Union Territories to strengthen surveillance, hospital preparedness, and rapid response systems. Health Secretary Punya Salila Srivastava highlighted the need for adequate preparedness due to growing international trade and travel, despite the low current risk to India. States are asked to intensify surveillance under the Integrated Disease Surveillance Programme (IDSP), identify isolation facilities, ensure trained personnel and PPE, and reinforce infection prevention and control practices in healthcare settings.
- The Centre has directed all States and UTs to strengthen Ebola surveillance and preparedness.
- This directive follows the WHO's declaration of an Ebola outbreak in DRC and Uganda as a Public Health Emergency of International Concern.
- States are advised to intensify surveillance under the Integrated Disease Surveillance Programme (IDSP) for individuals with recent travel history to affected regions.
India has postponed the Fourth India-Africa Forum Summit (IAFS-IV), originally scheduled from May 28 to 31 in New Delhi, due to the evolving Ebola public health emergency in Africa. The Ministry of External Affairs (MEA) and the African Union (AU) jointly announced the decision, emphasizing consultations regarding the health situation. This is not the first time; the third IAFS in 2014 was also postponed due to an Ebola outbreak. India has expressed solidarity and pledged support to African governments, adopting an "Africa-led" approach. The International Big Cat Alliance (IBCA) Summit, planned concurrently, has also been deferred. India has issued a health advisory for travelers from high-risk Ebola-affected countries.
- India postponed the Fourth India-Africa Forum Summit and the International Big Cat Alliance Summit due to the Ebola crisis in Africa.
- The decision was made after consultations between the MEA and the African Union, citing the evolving health situation.
- India has pledged support to African nations in dealing with the crisis, adopting an 'Africa-led' approach.
The Supreme Court sought a response from the Centre and States on a plea highlighting the lack of uniform excise laws across States, leading to deceptive packaging and promotion of cheap alcohol. The Chief Justice emphasized the need for a clear, uniform, and harmonious definition of terms like "bottle" and "juice" in excise laws. The petition argued that liquor packaged as "juice" poses health risks, increases ease of smuggling, and contributes to public consumption, especially among juveniles. The court noted that such packaging makes it difficult to distinguish liquor from actual juice, leading to public health concerns and inflation worries.
- The Supreme Court has raised concerns about the lack of uniform excise laws across Indian States.
- The court called for a clear and consistent definition of terms like "liquor" and "bottle" in excise laws.
- Deceptive packaging of cheap alcohol as "juice" poses significant public health risks, especially for juveniles.
A 73-year-old woman in Kerala died from primary amoebic meningoencephalitis (PAM), a rare but lethal central nervous system infection. The infection is caused by Naegleria fowleri, a free-living amoeba found in freshwater, lakes, rivers, and poorly maintained swimming pools. The woman developed symptoms like fever and headache on May 6 and is suspected to have contracted the infection by washing her face with water from a canal. Following her death, local health authorities initiated superchlorination of water sources, including wells, to prevent further spread.
- A woman in Kerala died from Primary Amoebic Meningoencephalitis (PAM).
- PAM is a rare and lethal central nervous system infection.
- It is caused by Naegleria fowleri, a free-living amoeba found in freshwater bodies and poorly maintained pools.
The World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) over an Ebola outbreak in Central Africa, specifically involving the uncommon Bundibugyo strain. This strain's efficacy against standard countermeasures like vaccines is currently untested. The outbreak, notified in the Democratic Republic of Congo (DRC) and Uganda, is concerning due to ongoing conflict, displacement, and potential for undetected spread. WHO's early alert aims to solicit global cooperation for effective patient and contact tracing, intensive support, safe burials, vaccinations (if effective), and social mobilization to control the disease, which has a 25-50% fatality rate.
- WHO declared a Public Health Emergency of International Concern (PHEIC) for an Ebola outbreak in Central Africa, involving the uncommon Bundibugyo strain.
- The efficacy of existing vaccines and therapies against the Bundibugyo strain is currently unknown, raising concerns.
- The outbreak is concentrated in the Democratic Republic of Congo (DRC) and Uganda, with risks of wider spread due to regional conflict and displacement.
The Supreme Court refused to modify its 2025 order directing states and Union Territories to remove stray dogs from high-footfall public institutions. It clarified that such dogs cannot be "re-released" even after vaccination and sterilization. A Bench of Justices Vikram Nath, Sandeep Mehta, and N.V. Anjaria also permitted legally permissible measures, including euthanasia, for "rabid, incurably ill or demonstrably dangerous or aggressive dogs." The court emphasized the need for a balance between human safety and animal welfare, directing states to establish at least one Animal Birth Control (ABC) centre in every district and ensure proper infrastructure and trained personnel.
- The Supreme Court upheld its 2025 order for the removal of stray dogs from public institutions, clarifying they cannot be re-released post-vaccination/sterilization.
- Euthanasia is now permitted for stray dogs that are rabid, incurably ill, or demonstrably dangerous/aggressive.
- The court stressed the importance of balancing the right to live with dignity for humans and the welfare of animals.
The WHO declared a Public Health Emergency of International Concern (PHEIC) over the Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda, driven by the Bundibugyo ebolavirus strain. This highest global health alert signifies a serious, sudden, unexpected, or unusual event posing an international risk. The outbreak has caused confirmed and suspected cases and deaths, with cases reported in Ituri Province (DRC) and Kampala (Uganda). Ebola, a zoonotic disease, spreads through bodily fluids. The response focuses on rapid isolation, intensive supportive care, case/contact tracing, safe burials, infection control, and deploying approved vaccines and monoclonal antibodies, alongside social mobilization campaigns to build trust.
- The WHO declared a Public Health Emergency of International Concern (PHEIC) for the Ebola outbreak in DRC and Uganda.
- The outbreak is caused by the Bundibugyo ebolavirus strain, a severe and often fatal zoonotic disease.
- PHEIC signifies a serious health event with international spread potential, requiring a coordinated global response.
The World Health Organization (WHO) has declared the Ebola disease outbreak in Congo and neighboring Uganda, caused by a rare Bundibugyo virus, a public health emergency of international concern. With over 300 suspected cases and 88 deaths, and a confirmed case in Congo's capital Kinshasa, the outbreak poses a risk of international spread. Ebola is highly contagious, transmitted via bodily fluids, and often fatal. The WHO emphasized the seriousness and need for a coordinated international response, though it advised against closing international borders. There are currently no approved therapeutics or vaccines for the Bundibugyo variant.
- The WHO declared the Ebola outbreak in Congo and Uganda a public health emergency of international concern.
- The outbreak is caused by the rare Bundibugyo virus, a variant of Ebola for which no approved treatments or vaccines exist.
- Ebola is highly contagious and transmitted through bodily fluids, with over 300 suspected cases and 88 deaths reported.
Africa's top public health agency confirmed a new Ebola outbreak in the Ituri province of the Democratic Republic of Congo. So far, 65 deaths have been recorded out of 246 suspected cases. Initial findings suggest the presence of a non-Zaire strain of the virus, with sequencing ongoing to further characterize it. This outbreak marks another public health challenge for the region, requiring immediate response and containment efforts to prevent wider spread. The confirmation of a new strain highlights the ongoing vigilance needed for viral surveillance and rapid diagnostic capabilities in affected areas.
- A new Ebola outbreak has been confirmed in the Ituri province of the Democratic Republic of Congo.
- The outbreak has resulted in 65 deaths out of 246 suspected cases.
- Initial findings indicate the presence of a non-Zaire strain of the Ebola virus.
The article discusses the proposed name change from Polycystic Ovary Syndrome (PCOS) to Polycystic Ovarian Syndrome (PMOS) to better reflect the condition's systemic nature beyond just ovarian cysts. PCOS affects 1 in 5 women globally and is a leading cause of infertility, but its symptoms extend to metabolic, cardiovascular, and mental health issues. The name change aims to reduce stigma, improve diagnosis, and encourage a holistic approach to treatment. However, some argue against the change, citing potential confusion and the need for more research into the condition's diverse manifestations. The debate highlights the importance of accurate terminology in medical understanding and patient care.
- The proposed name change from PCOS to PMOS aims to better reflect the systemic nature of the condition beyond just ovarian cysts.
- PCOS affects 1 in 5 women globally and is a leading cause of infertility, with symptoms extending to metabolic, cardiovascular, and mental health.
- The name change seeks to reduce stigma, improve diagnosis, and promote a more holistic treatment approach.
India's medical education system, despite expanding MBBS seats, faces significant challenges in quality, faculty shortages, infrastructure, and research. The editorial argues for a shift from quantity to quality, emphasizing the need for robust faculty development, modern infrastructure, and integration of technology like AI. It highlights issues such as the lack of independent regulatory bodies, outdated curricula, and inadequate research focus. Recommendations include strengthening faculty, promoting interdisciplinary research, and fostering a culture of innovation to produce competent, compassionate, and future-ready healthcare professionals, aligning with the vision of a "constructive relationship of strategic stability" for the next three years and beyond.
- India's medical education system is expanding in quantity but lacks sufficient quality, faculty, and infrastructure.
- There is a critical need for independent regulatory bodies and a shift towards a competency-based, modern curriculum.
- Integrating technology like AI and promoting interdisciplinary research are essential for future-ready medical professionals.
India's cities are increasingly vulnerable to extreme heat, making cooling a necessity rather than a luxury. The editorial highlights the severe health and economic impacts of heatwaves, disproportionately affecting vulnerable populations and outdoor workers. Current cooling solutions are often energy-intensive and contribute to climate change, creating a vicious cycle. There is an urgent need for a "cooling doctrine" that integrates passive cooling techniques, energy-efficient appliances, and green infrastructure. Policy interventions, including building codes, urban planning, and public awareness campaigns, are crucial to ensure equitable and sustainable access to cooling, protecting lives and livelihoods in a warming climate.
- Extreme heat is a growing threat to Indian cities, making cooling an essential public health and economic issue.
- Heatwaves disproportionately affect vulnerable populations, including outdoor workers and those in informal settlements.
- Current cooling methods are often energy-intensive, exacerbating climate change and creating a feedback loop.
India needs to transition from a curative to a preventive health culture to address its significant health challenges effectively. The editorial highlights that while India has made strides in healthcare access, the focus remains largely on treatment rather than prevention. It emphasizes the importance of community participation, health education, and addressing social determinants of health like nutrition and sanitation. Building a preventive culture requires integrating traditional knowledge with modern medicine, promoting healthy lifestyles, and ensuring equitable access to primary healthcare. This shift is crucial for improving public health outcomes and achieving sustainable well-being across the nation.
- India's healthcare system needs to pivot from a curative to a preventive approach to address health challenges effectively.
- Community participation and widespread health education are crucial for fostering a preventive health culture.
- Addressing social determinants of health, including nutrition, sanitation, and clean environments, is fundamental to prevention.
A WHO flagship report estimates that the COVID-19 pandemic caused 22.1 million excess deaths globally between 2020 and 2023, more than three times the officially reported COVID-19 deaths. This figure includes indirect deaths and highlights vulnerabilities in global health systems, reversing a decade of gains in life expectancy. Despite this, the report notes progress in other areas: new HIV infections fell by 40% (2010-2024), and tobacco/alcohol consumption declined. Access to safe water, sanitation, and hygiene also significantly expanded. However, challenges like increased malaria incidence and widespread violence against women persist.
- The COVID-19 pandemic is estimated to have caused 22.1 million excess deaths globally between 2020 and 2023, far exceeding official figures.
- The pandemic exposed significant vulnerabilities in global health systems and reversed a decade of progress in life expectancy.
- Despite the pandemic's impact, there were notable improvements in reducing new HIV infections and decreasing tobacco and alcohol consumption.